Mersana Therapeutics, Inc.Mersana Therapeutics, Inc.Mersana Therapeutics, Inc.

Mersana Therapeutics, Inc.

No trades
See on Supercharts

Price target

167.860.000.00%
The 7 analysts offering 1 year price forecasts for MRSN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to MRSN in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


MRSN EPS for the last quarter is −4.75 USD despite the estimation of −4.81 USD. In the next quarter EPS is expected to reach −3.87 USD. Track more of Mersana Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Mersana Therapeutics, Inc. revenue is expected to reach ‪6.19 M‬ USD. Check out Mersana Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, MRSN price target is 167.86 USD with a max estimate of 325.00 USD and a min estimate of 50.00 USD. Check if this forecast comes true in a year, meanwhile watch Mersana Therapeutics, Inc. stock price chart and keep track of the current situation with MRSN news and stock market news.
We've gathered opinions of 8 analysts rating MRSN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.